利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

40 条记录 (耗时 0.042 秒)

    Method for locating tumors prior to needle biopsy
    1.
    发明授权
    Method for locating tumors prior to needle biopsy 失效
    针刺活检前定位肿瘤的方法

    公开(公告)号：US5396897A

    公开(公告)日：1995-03-14

    申请号：US058682

    申请日：1993-05-03

    申请人： Rakesh K. Jain ,  Adam Stacy-Clear ,  Yves Boucher ,  Richard Moore ,  Daniel B. Kopans

    发明人： Rakesh K. Jain ,  Adam Stacy-Clear ,  Yves Boucher ,  Richard Moore ,  Daniel B. Kopans

    IPC分类号： A61B5/03 ,  A61B19/00 ,  A61B5/00

    CPC分类号： A61B5/03 ,  A61B2090/3904

    摘要： A method for locating a lesion within a tissue mass, includes steps of measuring a selected parameter at two or more points in at least one path through the tissue mass, the measure of the selected parameter in a lesion being different from that in normal tissue. Also, apparatus for measuring a tissue parameter at two or more points in at least one path through the tissue mass includes an insertion needle, distally sharpened and made sufficiently rigid so that it can be inserted distal end foremost into the tissue mass along the path, and, insertible with the needle, a sensor capable of prodding a measure of the tissue parameter at a point in the tissue mass along the path. Where the parameter is selected as one that has a measure different in a lesion type, the apparatus can be used in carrying out the method, whereby a measure at a point in the tissue mass of the selected tissue parameter provided by the sensor indicates that the point is within a lesion. In an embodiment for measuring interstitial fluid pressure in the tissue mass, the sensor includes a tube slidably engageable within the lumen of the insertion needle; the sensor tube is closed at a distal end, and the walls of the sensor tube and the insertion needle are prodded distally with ports, positioned in relation to the respective distal ends such that when the sensor tube is engaged within the insertion tube lumen the ports can be substantially aligned to provide fluid communication between the lumen of the sensor tube and the tissue adjacent the ports; the sensor tube lumen contains a plurality of filaments, and is operationally connected to a pressure measurement deuce such that the pressure measurement deuce is responsive to fluid pressure within the sensor tube lumen.

    摘要翻译： 一种用于定位组织块内的损伤的方法，包括以下步骤：在至少一个穿过组织块的路径中的两个或多个点处测量所选择的参数，所述病变中所选参数的测量与正常组织中的不同。 此外，在穿过组织块的至少一条路径中的两个或更多个点处测量组织参数的装置包括：远端切削并制成足够刚性的插入针，使得其可以沿着路径最前端插入组织块， 并且能够与针一起插入能够沿着路径刺激组织块中的一点处的组织参数的测量的传感器。 如果参数被选择为具有在病变类型中不同的度量的参数，则可以使用该装置来执行该方法，由此由传感器提供的所选择的组织参数的组织块中的点处的度量指示： 点在病变内。 在用于测量组织块中的组织液压的实施例中，传感器包括可滑动地接合在插入针的内腔内的管; 传感器管在远端封闭，并且传感器管和插入针的壁通过端口向远端方向延伸，其位置相对于相应的远端，使得当传感器管接合在插入管腔内时，端口 可以基本上对准以提供传感器管的内腔和邻近端口的组织之间的流体连通; 传感器管腔包含多个细丝，并且可操作地连接到压力测量装置，使得压力测量装置响应于传感器管腔内的流体压力。

    TREATMENT OF ANGIOGENIC- OR VASCULAR-ASSOCIATED DISEASES
    5.
    发明申请
    TREATMENT OF ANGIOGENIC- OR VASCULAR-ASSOCIATED DISEASES 审中-公开
    治疗血管生成或血管相关疾病

    公开(公告)号：US20140161720A1

    公开(公告)日：2014-06-12

    申请号：US14119532

    申请日：2012-05-25

    申请人： Igor Garkavtsev ,  Rakesh K. Jain

    发明人： Igor Garkavtsev ,  Rakesh K. Jain

    IPC分类号： C07D311/92 ,  A61K36/185 ,  A61K31/352 ,  A61K45/06 ,  A61K47/30

    CPC分类号： C07D311/92 ,  A61K31/337 ,  A61K31/352 ,  A61K36/185 ,  A61K45/06 ,  A61K47/30 ,  A61K2300/00

    摘要： Described herein are methods and compositions comprising a compound of formula (I), e.g., dehydro-alpha-lapachone, or an analog, derivative, isomer, prodrug, or pharmaceutically acceptable salt thereof, for treatment and/or prevention of angiogenic- or vascular-associated diseases or disorders. The compound has anti-vascular activity. In some embodiments, the compound has anti-vascular activity that targets pathways other than VEGF pathways. In some embodiments, the compound or the composition further comprises anti-tumor activity. In some embodiments, the compound or the composition can decrease adhesion or motility of at least one cell (e.g., endothelial cells or cancer cells).

    摘要翻译： 本文描述了包含式（I）化合物的方法和组合物，例如脱氢-α-拉帕酮或其类似物，衍生物，异构体，前药或药学上可接受的盐，用于治疗和/或预防血管生成或血管 相关的疾病或病症。 该化合物具有抗血管活性。 在一些实施方案中，化合物具有靶向除VEGF途径之外的途径的抗血管活性。 在一些实施方案中，化合物或组合物还包含抗肿瘤活性。 在一些实施方案中，化合物或组合物可降低至少一种细胞（例如内皮细胞或癌细胞）的粘附或运动性。